eXoZymes, Inc.(EXOZ)

Biotechnology · Monrovia, CA

$5.520.00 (0.00%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

Operating Cash Flow Yield: N/A

Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The operating cash flow yield is N/A as of 2026-10-06T21:51:36.387Z.

Stored calculation inputs

Calculation as of: 2026-10-06T21:51:36.387Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

TTM operating cash flow · period ending 2026-06-30: -6,995,227
Quote market capitalization: 51,233,102

FMP input reference: 787788ea5c712995087b0511470a3bc1500b131fb4a88c1f5ff44ca2612ce4c8

P/OCF Ratio|FCF Yield|Earnings Yield|EBITDA Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

EXOZ Operating Cash Flow Yield Metrics

OPERATING CASH FLOW YIELD

N/A

EXOZ Competitors' Operating Cash Flow Yield

EXOZ

eXoZymes, Inc.

Current

Market Cap

$51.23M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TENX

Tenax Therapeutics, Inc.

vs EXOZ

Market Cap

$51.19M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DWTX

Dogwood Therapeutics, Inc.

vs EXOZ

Market Cap

$51.12M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IMA

ImageneBio Inc

vs EXOZ

Market Cap

$51.88M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ELOX

Eloxx Pharmaceuticals, Inc.

vs EXOZ

Market Cap

$51.99M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BTMD

biote Corp.

vs EXOZ

Market Cap

$50.28M

Operating Cash Flow Yield

48.46%

TTM Avg

50.32%

3Y Avg

31.17%

5Y Avg

36.60%

COCH

Envoy Medical, Inc.

vs EXOZ

Market Cap

$50.27M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ZYBT

Zhengye Biotechnology Holding Limited

vs EXOZ

Market Cap

$52.60M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INMB

INmune Bio, Inc.

vs EXOZ

Market Cap

$49.71M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MDAI

Spectral AI, Inc.

vs EXOZ

Market Cap

$52.83M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	OPERATING CASH FLOW YIELD	TTM	3Y	5Y
eXoZymes, Inc. (EXOZ)	$51.23M	N/A	N/A	N/A	N/A
Tenax Therapeutics, Inc. (TENX)vs ›	$51.19M	N/A	N/A	N/A	N/A
Dogwood Therapeutics, Inc. (DWTX)vs ›	$51.12M	N/A	N/A	N/A	N/A
ImageneBio Inc (IMA)vs ›	$51.88M	N/A	N/A	N/A	N/A
Eloxx Pharmaceuticals, Inc. (ELOX)vs ›	$51.99M	N/A	N/A	N/A	N/A
biote Corp. (BTMD)vs ›	$50.28M	48.46%	50.32%	31.17%	36.60%
Envoy Medical, Inc. (COCH)vs ›	$50.27M	N/A	N/A	N/A	N/A
Zhengye Biotechnology Holding Limited (ZYBT)vs ›	$52.60M	N/A	N/A	N/A	N/A
INmune Bio, Inc. (INMB)vs ›	$49.71M	N/A	N/A	N/A	N/A
Spectral AI, Inc. (MDAI)vs ›	$52.83M	N/A	N/A	N/A	N/A

Operating Cash Flow Yield Formula & Definition

OCF Yield = TTM Operating Cash Flow / Market Cap

Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Operating Cash Flow Yield: N/A

EXOZ Operating Cash Flow Yield Metrics

EXOZ Competitors' Operating Cash Flow Yield

Operating Cash Flow Yield Formula & Definition

Related Metrics